期刊
ANTIOXIDANTS
卷 10, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/antiox10030373
关键词
hydrogen sulfide; reactive oxygen species; H2S donors; cardiorenal syndrome; thiosulfate
资金
- Netherlands CardioVascular Research Initiative
- Dutch Heart Foundation [CVON2014-11]
- Dutch Kidney Foundation [17O16]
Hydrogen sulfide (H2S) serves as a crucial gaseous signaling molecule in physiological and pathophysiological processes, maintaining redox balance and promoting antioxidant mechanisms. Depletion of H2S is implicated in various diseases, leading to research interest in therapeutic interventions.
Hydrogen sulfide (H2S) is an essential gaseous signaling molecule. Research on its role in physiological and pathophysiological processes has greatly expanded. Endogenous enzymatic production through the transsulfuration and cysteine catabolism pathways can occur in the kidneys and blood vessels. Furthermore, non-enzymatic pathways are present throughout the body. In the renal and cardiovascular system, H2S plays an important role in maintaining the redox status at safe levels by promoting scavenging of reactive oxygen species (ROS). H2S also modifies cysteine residues on key signaling molecules such as keap1/Nrf2, NF kappa B, and HIF-1 alpha, thereby promoting anti-oxidant mechanisms. Depletion of H2S is implicated in many age-related and cardiorenal diseases, all having oxidative stress as a major contributor. Current research suggests potential for H2S-based therapies, however, therapeutic interventions have been limited to studies in animal models. Beyond H2S use as direct treatment, it could improve procedures such as transplantation, stem cell therapy, and the safety and efficacy of drugs including NSAIDs and ACE inhibitors. All in all, H2S is a prime subject for further research with potential for clinical use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据